New York S 7668: Relates to amending the authorization for the imposition of additional sales and compensating use tax in Herkimer county

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S07668 Summary:

BILL NOS07668A

&nbsp

SAME ASNo Same As

&nbsp

SPONSORFERNANDEZ

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Add 392-k, Gen Bus L

&nbsp

Prohibits the knowing sale of xylazine above a certain weight to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Go to top S07668 Actions:

BILL NOS07668A

&nbsp

04/28/2025REFERRED TO CONSUMER PROTECTION

05/19/20251ST REPORT CAL.1135

05/20/20252ND REPORT CAL.

05/21/2025AMENDED 7668A

05/21/2025ADVANCED TO THIRD READING 

06/13/2025COMMITTED TO RULES

01/07/2026REFERRED TO CONSUMER PROTECTION

Go to topS07668 Committee&nbspVotes:

Go to topS07668 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS07668 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 7668--A
 Cal. No. 1135

 2025-2026 Regular Sessions

 IN SENATE

 April 28, 2025
 ___________

 Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
 printed to be committed to the Committee on Consumer Protection --
 reported favorably from said committee, ordered to first and second
 report, amended on second report, ordered to a third reading, and to
 be reprinted as amended, retaining its place in the order of third
 reading

 AN ACT to amend the general business law, in relation to prohibiting the
 sale of xylazine above a certain weight

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The general business law is amended by adding a new section
 2 392-k to read as follows:
 3 § 392-k. Sale of xylazine. 1. For purposes of this section, the term
 4 "xylazine" shall mean a pharmaceutical drug used for sedation, anes-
 5 thesia, muscle relaxation, and analgesia in animals such as horses,
 6 cattle, and other non-human mammals.
 7 2. The provisions of this section shall apply only to the sale, offer
 8 for sale, delivery, or distribution of xylazine in quantities of fifty
 9 grams or more per occurrence.
 10 3. No corporation, partnership, limited liability company, firm,
 11 online platform, or any other business entity doing business within this
 12 state shall knowingly sell, offer for sale, or deliver fifty grams or
 13 more of xylazine to individuals without proof of its intended use for
 14 institutional, veterinary, or scientific purposes.
 15 4. No corporation, partnership, limited liability company, firm,
 16 online platform, or other business entity doing business within this
 17 state shall knowingly sell, offer for sale, or deliver fifty grams or
 18 more of xylazine to individuals under the age of twenty-one.
 19 5. Any corporation, partnership, limited liability company, firm,
 20 online platform, or other business entity doing business within this
 21 state which knowingly sells, offers for sale, or distributes fifty grams

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD02623-06-5

 S. 7668--A 2

 1 or more of xylazine, shall require and retain sales records, proof of
 2 age, and proof of use from all purchasers.
 3 6. Any corporation, partnership, limited liability company, firm,
 4 online platform, or other business entity doing business within this
 5 state that violates the provisions of this section by knowingly selling,
 6 offering for sale, or delivering fifty grams or more of xylazine shall
 7 be subject to a civil penalty of not more than three thousand dollars
 8 for a first violation, and sixty-five hundred dollars for each subse-
 9 quent violation, recoverable in an action by the attorney general of the
 10 state of New York. All funds collected or received by the state from
 11 civil penalties imposed under this section shall be deposited in the New
 12 York state drug treatment and public education fund established pursuant
 13 to section ninety-nine-jj of the state finance law.
 14 § 2. This act shall take effect on the ninetieth day after it shall
 15 have become a law.

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps